Literature DB >> 8836298

Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa.

H Boecker1, A Weindl, K Leenders, A Antonini, T Kuwert, F Kruggel, H Grafin von Einsiedel, B Conrad.   

Abstract

We present a 71 year old woman with predominantly right sided parkinsonism of sudden onset, but without tremor. Magnetic resonance imaging (MRI) depicted lesions affecting the substantia nigra (SN) bilaterally, but more pronounced on the left side. There were no other discernible structural lesions. Using positron emission tomography (PET), we investigated regional cerebral metabolic rate of glucose (rCMRG) using the tracer [18F]-fluorodeoxyglucose (FDG), and striatal dopa decarboxylase capacity using the tracer [18F]-L-6-fluorodopa (FDOPA). The degree and pattern of distribution of FDOPA uptake reductions (putamen > caudate nuclei) were similar to those in idiopathic Parkinson's disease (PD). FDG uptake also revealed similar changes (reductions in frontal cortex and cerebellum, but increases in thalamus), except for putamen which showed reduced rCMRG. In conclusion, the absence of tremor at rest accords with experimental SN lesions. The PET findings in this atypical condition are explained in terms of deafferentation of various brain regions involved in motor control. Furthermore, they illustrate the metabolic effects related to acute focal lesions of the SN as opposed to the progressive degeneration in idiopathic PD and may serve to help unravel the complicated pathophysiology underlying these conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836298     DOI: 10.1111/j.1600-0404.1996.tb00015.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  The L-dopa response in vascular parkinsonism.

Authors:  J C M Zijlmans; R Katzenschlager; S E Daniel; A J L Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

2.  Imaging of dopamine transporters and D2 receptors in vascular parkinsonism: a report of four cases.

Authors:  M Plotkin; H Amthauer; S Quill; F Marzinzik; F Klostermann; S Klaffke; A Kivi; M Gutberlet; R Felix; A Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2005-02-22       Impact factor: 3.575

3.  Early- and late-phase 18F-FP-CIT PET images in vascular parkinsonism due to midbrain infarct.

Authors:  Song Hwangbo; Yooha Hong; Sang Won Choi; Joo Yong Kim; You Mie Han; Suk Yun Kang
Journal:  Neurol Sci       Date:  2018-12-07       Impact factor: 3.307

4.  Posthemorrhagic Hemiparkinsonism Treated by Unilateral Pallidal Stimulation.

Authors:  Josefina Martínez-Simón; Carmen Sáez-Zea; Majed J Katati; Francisco Escamilla-Sevilla; Adolfo Mínguez-Castellanos
Journal:  Mov Disord Clin Pract       Date:  2014-05-19

5.  Extranigral extension of structural midbrain lesions overshadows parkinsonism.

Authors:  Hee Jin Kim; Ji Young Yun; Jong-Min Kim; Yu Kyeong Kim; Gwanhee Erm; Sang Eun Kim; Beom S Jeon
Journal:  J Neural Transm (Vienna)       Date:  2011-02-05       Impact factor: 3.575

6.  Impact of subcortical white matter lesions on dopamine transporter SPECT.

Authors:  Elisabeth Funke; Andreas Kupsch; Ralph Buchert; Winfried Brenner; Michail Plotkin
Journal:  J Neural Transm (Vienna)       Date:  2013-01-24       Impact factor: 3.575

Review 7.  Neuroimaging in Vascular Parkinsonism.

Authors:  Karen K Y Ma; Shi Lin; Vincent C T Mok
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.